HHMI
EMN icon

Howard Hughes Medical Institute’s Eastman Chemical EMN Stock Holding History

Howard Hughes Medical Institute’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24
Closed -$1.51K – 501
2025
Q3 		$1.51K Hold
24
– – ﹤0.01% 493
2025
Q2 		$1.79K Buy
+24
New +$1.89K ﹤0.01% 473
2014
Q2 		– Sell
-642
Closed -$55K – 193
2014
Q1 		$55K Buy
+642
New +$52.6K 0.01% 152

Other funds holding EMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howard Hughes Medical Institute's EMN Position: Q4 2025 in Review

Howard Hughes Medical Institute sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 24 shares — an estimated $1.51K sold.

Howard Hughes Medical Institute first reported a position in EMN in Q1 2014 and held it in 3 quarters. The position peaked at $55K in Q1 2014. 631 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Howard Hughes Medical Institute reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 24 Eastman Chemical shares in Q4 2025, an estimated $1.51K.
  • Howard Hughes Medical Institute first reported a position in Eastman Chemical in Q1 2014 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Eastman Chemical position peaked at $55K in Q1 2014.
  • 631 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2025, filed 17 Feb 2026.